These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Surfactant of the lung. Heinemann HO Adv Intern Med; 1968; 14():83-105. PubMed ID: 4883747 [No Abstract] [Full Text] [Related]
4. [Pulmonary surfactan. Current physiological and physiopathological concepts]. Pariente R Presse Med (1893); 1969 Nov; 77(50):1871-2. PubMed ID: 5197179 [No Abstract] [Full Text] [Related]
5. [Pulmonary surfactant: anti-atelectasis factor]. Ouellet Y Laval Med; 1970 May; 41(5):627-30. PubMed ID: 4928481 [No Abstract] [Full Text] [Related]
6. Early and late surfactant treatments in baboon model of hyaline membrane disease. Maeta H; Vidyasagar D; Raju TN; Bhat R; Matsuda H Pediatrics; 1988 Feb; 81(2):277-83. PubMed ID: 3340477 [TBL] [Abstract][Full Text] [Related]
7. The influence of surface active substances on alveolar mechanics in the respiratory distress syndrome. Rüfer R Respiration; 1968; 25(6):441-57. PubMed ID: 5687215 [No Abstract] [Full Text] [Related]
9. [Pulmonary surfactant]. Murakami K; Ono K; Fujiwara T; Sawada H; Mori I Nihon Ishikai Zasshi; 1971 Jul; 66(1):100-16. PubMed ID: 4254974 [No Abstract] [Full Text] [Related]
10. [Surface tension within the lung and hyaline membrane disease]. Benzer H; Lempert J; Regele H Wien Klin Wochenschr; 1969 Feb; 81(9):145-9. PubMed ID: 5784059 [No Abstract] [Full Text] [Related]
11. [The surface-active substance of the lung (antiatelectasis factor), a literature review]. Renovanz HD; Krishnabhakdi C Dtsch Med J; 1969 Mar; 20(6):194-200. PubMed ID: 4892894 [No Abstract] [Full Text] [Related]
12. [Importance of surface active substances in the lung]. Kadlec K; Kandus J Vnitr Lek; 1972 Jun; 18(6):521-31. PubMed ID: 5068058 [No Abstract] [Full Text] [Related]
13. [Morphology of the pathological lung in the newborn]. Regele H Anaesthesist; 1971 Jul; 20(7):259-61. PubMed ID: 5569072 [No Abstract] [Full Text] [Related]
14. [Lung coating with surface-active material using the ultrasonic nebulizer]. Benzer H; Baum M; Tölle W Z Erkr Atmungsorgane Folia Bronchol; 1971; 135(3):353-7. PubMed ID: 5211713 [No Abstract] [Full Text] [Related]
15. The effect of prematurity and hyaline membrane disease on oxygen exchange in the lung. Woodrum DE; Oliver TK; Hodson WA Pediatrics; 1972 Sep; 50(3):380-6. PubMed ID: 5056411 [No Abstract] [Full Text] [Related]
16. A new look at the treatment of hyaline membrane disease. Gluck L Mead Johnson Symp Perinat Dev Med; 1978; (14):59-65. PubMed ID: 583438 [No Abstract] [Full Text] [Related]
17. [Results of artificial respiration therapy in hyaline membrane disease of the premature infant]. de Bruijne JI; Deen L; Koppe JG Ned Tijdschr Verloskd Gynaecol; 1969 Oct; 69(5):392-400. PubMed ID: 5345138 [No Abstract] [Full Text] [Related]